Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

by Papanicolaou Sotiria, Athanasakis Kostas, Ollandezos Markos, Kousoulakou Hara, Geitona Maria, Kyriopoulos Ioannis
Published 2009-06-01

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

by Papanicolaou Sotiria, Athanasakis Kostas, Ollandezos Markos, Kousoulakou Hara, Geitona Maria, Kyriopoulos Ioannis
Published 2008-08-01

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

by Einarson Thomas R, Geitona Maria, Chaidemenos Alexandros, Karpouza Vasiliki, Mougiakos Theodoros, Paterakis Periklis, Ploumpidis Dimitrios, Potamitis-Komis Dionyssios, Zilbershtein Roman, Vicente Colin, Piwko Charles, Kakkavas Panagiotis, Paparouni Konstantina, Jensen Rasmus C D, Hemels Michiel E H
Published 2012-07-01